ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
Joshua P. Plotnik(AbbVie (United States)), Peter C. Hollenhorst(Indiana University Bloomington), Justin A. Budka(Gilead Sciences (United Kingdom)), Mary W. Ferris(Indiana University Bloomington)
Cited by 123
Related Papers
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
|Genes & Development|2011|161
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
|Nature Medicine|2024|114
Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma
|Clinical Cancer Research|2018|95
Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells
|Cell Communication and Signaling|2015|75